Charlyne Hickey
Concepts (39)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Huntington Disease | 4 | 1995 | 30 |
Why?
|
Neurologic Examination | 2 | 1996 | 64 |
Why?
|
Cognition | 2 | 1996 | 97 |
Why?
|
Fluoxetine | 1 | 1997 | 8 |
Why?
|
Ubiquinone | 1 | 1996 | 11 |
Why?
|
Antidepressive Agents | 1 | 1997 | 46 |
Why?
|
Acetamides | 1 | 1996 | 20 |
Why?
|
Age of Onset | 1 | 1995 | 64 |
Why?
|
Neuroprotective Agents | 1 | 1996 | 60 |
Why?
|
Depressive Disorder | 1 | 1997 | 76 |
Why?
|
Neuropsychological Tests | 3 | 1996 | 113 |
Why?
|
HIV-1 | 1 | 1996 | 93 |
Why?
|
HIV Infections | 1 | 1996 | 136 |
Why?
|
Brain | 1 | 1996 | 305 |
Why?
|
Middle Aged | 5 | 1995 | 1161 |
Why?
|
Adult | 5 | 1995 | 1317 |
Why?
|
Double-Blind Method | 2 | 1996 | 274 |
Why?
|
Male | 5 | 1995 | 1553 |
Why?
|
Female | 5 | 1995 | 1643 |
Why?
|
Follow-Up Studies | 2 | 1995 | 553 |
Why?
|
Treatment Outcome | 2 | 1996 | 661 |
Why?
|
Placebos | 1 | 1997 | 110 |
Why?
|
Coenzymes | 1 | 1996 | 16 |
Why?
|
Drug Tolerance | 1 | 1996 | 26 |
Why?
|
Caudate Nucleus | 1 | 1996 | 14 |
Why?
|
Atrophy | 1 | 1996 | 41 |
Why?
|
Humans | 5 | 1995 | 1856 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1996 | 38 |
Why?
|
Drug Administration Schedule | 1 | 1996 | 191 |
Why?
|
Hippocampus | 1 | 1996 | 83 |
Why?
|
Activities of Daily Living | 1 | 1996 | 122 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1995 | 99 |
Why?
|
Aged | 2 | 1995 | 988 |
Why?
|
Sex Factors | 1 | 1995 | 284 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1996 | 431 |
Why?
|
Depression | 1 | 1995 | 118 |
Why?
|
Magnetic Resonance Imaging | 1 | 1996 | 294 |
Why?
|
Child | 1 | 1995 | 749 |
Why?
|
Adolescent | 1 | 1995 | 891 |
Why?
|
